References
Callaway E. Why a highly mutated coronavirus variant has scientists on alert. Nature 2023;620:934.
Sun H, Li Y, Liu P, Qiao C, Wang X, Wu L, et al. Structural basis of HCoV-19 fusion core and an effective inhibition peptide against virus entry. Emerg Microb Infect 2020;9:1238–41.
de Vries RD, Schmitz KS, Bovier FT, Predella C, Khao J, Noack D, et al. Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets. Science 2021;371:1379–82.
Wu L, Zheng A, Tang Y, Chai Y, Chen J, Cheng L, et al. A pan-coronavirus peptide inhibitor prevents SARS-CoV-2 infection in mice by intranasal delivery. Sci China Life Sci 2023;66:2201–13.
Hu Y, Zhu Y, Yu Y, Liu N, Ju X, Ding Q, et al. Design and characterization of novel SARS-CoV-2 fusion inhibitors with N-terminally extended HR2 peptides. Antivir Res 2023;212:105571.
Yang K, Wang C, Kreutzberger AJB, Ojha R, Kuivanen S, Couoh-Cardel S, et al. Nanomolar inhibition of SARS-CoV-2 infection by an unmodified peptide targeting the prehairpin intermediate of the spike protein. Proc Natl Acad Sci USA 2022;119:e2210990119.
Zhu J, Xiao G, Xu Y, Yuan F, Zheng C, Liu Y, et al. Following the rule: formation of the 6-helix bundle of the fusion core from severe acute respiratory syndrome coronavirus spike protein and identification of potent peptide inhibitors. Biochem Biophys Res Commun 2004;319:283–8.
Gao J, Lu G, Qi J, Li Y, Wu Y, Deng Y, et al. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol 2013;87:13134–40.
